Literature DB >> 28433697

Rab22a enhances CD147 recycling and is required for lung cancer cell migration and invasion.

Yang Zhou1, Bo Wu2, Jiang-Hua Li3, Gang Nan4, Jian-Li Jiang5, Zhi-Nan Chen6.   

Abstract

Rab22a is a member of the Ras-related small GTPase family, which plays a key role in regulating the recycling of cargo proteins entering cells through clathrin-independent endocytosis (CIE). Rab22a is overexpressed in different cancer types, including liver cancer, malignant melanoma, ovarian cancer and osteosarcoma. However, its oncogenic role remains unknown. In this study, we found that silencing of Rab22a suppressed the migration and invasion of lung cancer cells. Furthermore, Rab22a interacts with CD147, and knockdown of Rab22a blocks CD147 recycling and promotes CD147 degradation. Taken together, our findings indicate that Rab22a enhances recycling of CD147, which is required for lung cancer cell migration and invasion,and targeting CD147 recycling may be a rational strategy for lung cancer therapy.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  CD147; Lung cancer; Rab22a; Vesicle recycling

Mesh:

Substances:

Year:  2017        PMID: 28433697     DOI: 10.1016/j.yexcr.2017.04.020

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Expression of CD147 after neoadjuvant chemotherapy and its relationship with prognosis in patients with triple negative breast cancer.

Authors:  Wei Zhang; Hui Liu; Junjie Jiang; Yunyun Yang; Wenjie Wang; Zhengyan Jia
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

2.  Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway.

Authors:  Xue Luo; Jinping Wang; Jinxi Lu; Xi Wang; Yuan Miao; Qingchang Li; Xiaoman Li; Liang Wang
Journal:  Biomed Res Int       Date:  2022-06-15       Impact factor: 3.246

3.  MicroRNA-4268 inhibits cell proliferation via AKT/JNK signalling pathways by targeting Rab6B in human gastric cancer.

Authors:  Lingyu Zhao; Meng Xue; Lu Zhang; Bo Guo; Yannan Qin; Qiuyu Jiang; Ruifang Sun; Juang Yang; Lumin Wang; Liying Liu; Xiaofei Wang; Chen Huang; Dongdong Tong
Journal:  Cancer Gene Ther       Date:  2019-07-15       Impact factor: 5.987

4.  Role of miR-520b in non-small cell lung cancer.

Authors:  Linlin Zhang; Shuangquan Yu
Journal:  Exp Ther Med       Date:  2018-09-12       Impact factor: 2.447

5.  A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity.

Authors:  Sean M Santos; Mert Icyuz; Ilya Pound; Doreen William; Jingyu Guo; Brett A McKinney; Michael Niederweis; John Rodgers; John L Hartman
Journal:  Genes (Basel)       Date:  2019-09-30       Impact factor: 4.096

6.  Rab22a is a novel prognostic marker for cell progression in breast cancer.

Authors:  Miao He; Leihua Shen; Chengwei Jiang; Ge Gao; Keren Wang; Yan Jiao; Liang Sun; Yingnan Cui; Zirui Ke; Zhaoying Yang
Journal:  Int J Mol Med       Date:  2020-02-05       Impact factor: 4.101

7.  RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma.

Authors:  Wanfu Men; Wenya Li; Yu Li; Jungang Zhao; Xiaohan Qu; Peiwen Li; Shulei Gong
Journal:  J Cancer       Date:  2019-10-17       Impact factor: 4.207

8.  Arf6-driven endocytic recycling of CD147 determines HCC malignant phenotypes.

Authors:  Shanshan Qi; Linjia Su; Jing Li; Chuanshan Zhang; Zhe Ma; Guiqiu Liu; Qing Zhang; Guhe Jia; Yongjun Piao; Sihe Zhang
Journal:  J Exp Clin Cancer Res       Date:  2019-11-21

9.  miRNA-520c-3p accelerates progression of nasopharyngeal carcinoma via targeting RAB22A.

Authors:  Xiaohan Sun; Wenrui Xu; Chuanshan Zang; Na Li
Journal:  Oncol Lett       Date:  2019-11-25       Impact factor: 2.967

10.  ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancer.

Authors:  Roxsan Manshouri; Etienne Coyaud; Samrat T Kundu; David H Peng; Sabrina A Stratton; Kendra Alton; Rakhee Bajaj; Jared J Fradette; Rosalba Minelli; Michael D Peoples; Alessandro Carugo; Fengju Chen; Christopher Bristow; Jeffrey J Kovacs; Michelle C Barton; Tim Heffernan; Chad J Creighton; Brian Raught; Don L Gibbons
Journal:  Nat Commun       Date:  2019-11-12       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.